HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Westhuyzen, J. Search for Related Content PubMed PubMed Citation Articles by Westhuyzen, J.

Cystatin C: a Promising Marker and Predictor of Impaired Renal Function

Address correspondence to Justin Westhuyzen, Ph.D., Department of Medicine, Christchurch School of Medicine & Health Sciences, University of Otago, PO Box 4345, Christchurch, New Zealand; tel 64 3 364 0017; fax 64 3 364 0935; e-mail j.westhuyzen{at}chmeds.ac.nz.

Cystatin C is a relatively stable protein in serum and heparinized plasma that shows promise as a convenient measure of glomerular filtration rate (GFR). However, it is becoming clear that the relationship between cystatin C and GFR can depend on the clinical presentation. Factors influencing cystatin C levels are those that affect the rate of synthesis of the protein, such as thyroid status and the use of steroids. As with all laboratory tests, results should be interpreted in the light of the method’s known limitations and in conjunction with other clinical and laboratory information. Nevertheless, accumulating evidence suggests that cystatin C is a useful biomarker for renal function, and may even be the method of choice in a range of clinical situations, from GFR surveillance in diabetics to the assessment of acute kidney injury in critically ill patients.

Keywords: acute renal failure, creatinine, cystatin C, glomerular filtration rate

This article has been cited by other articles:

				S. Y. Cho, H. J. Lee, J.-T. Suh, W.-H. Hahn, B.-S. Cho, A. Lee, and J.-S. Suh The Significance of Serum Cystatin C Accompanied by a Normal Serum Creatinine Level in Pediatric Patients With Chronic Kidney Disease Lab Med, September 1, 2011; 42(9): 549 - 552. [Abstract] [Full Text] [PDF]

				N. V. Voskoboev, T. S. Larson, A. D. Rule, and J. C. Lieske Importance of Cystatin C Assay Standardization Clin. Chem., August 1, 2011; 57(8): 1209 - 1211. [Full Text] [PDF]

				M. Nejat, J. W. Pickering, R. J. Walker, and Z. H. Endre Rapid detection of acute kidney injury by plasma cystatin C in the intensive care unit Nephrol. Dial. Transplant., October 1, 2010; 25(10): 3283 - 3289. [Abstract] [Full Text] [PDF]

				J. Li, W. Dunn, A. Breaud, D. Elliott, L. J. Sokoll, and W. Clarke Analytical Performance of 4 Automated Assays for Measurement of Cystatin C Clin. Chem., August 1, 2010; 56(8): 1336 - 1339. [Abstract] [Full Text] [PDF]

				V. Mitrovic, P. Seferovic, S. Dodic, M. Krotin, A. Neskovic, K. Dickstein, H. de Voogd, C. Bocker, D. Ziegler, M. Godes, et al. Cardio-Renal Effects of the A1 Adenosine Receptor Antagonist SLV320 in Patients With Heart Failure Circ Heart Fail, November 1, 2009; 2(6): 523 - 531. [Abstract] [Full Text] [PDF]

				Q.-P. Wang, J.-W. Gu, X.-H. Zhan, H. Li, and X.-H. Luo Assessment of glomerular filtration rate by serum cystatin C in patients undergoing coronary artery bypass grafting Ann Clin Biochem, November 1, 2009; 46(6): 495 - 500. [Abstract] [Full Text] [PDF]